Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

Advanced Flower Capital Inc. (AFCG)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

Advanced Flower Capital Inc. issued a press release on August 13, 2026, announcing its financial and operational results for the quarter ended June 30, 2026. The disclosure includes quarterly GAAP net investment income of $3.5 million ($0.15 per share), NAV per share of $8.25, and detailed operating results, portfolio activity, and liquidity metrics. This is a standard quarterly earnings release furnished under Item 2.02 with the full press release attached as Exhibit 99.1.

View raw filing on EDGAR →

Intuitive Machines, Inc. (LUNR)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

The filing discloses Intuitive Machines' financial results for the second quarter ended June 30, 2026, via a press release issued on August 13, 2026. The press release reports record quarterly revenue of $206 million, record backlog of $1.8 billion, and provides full-year 2026 guidance of $900 million to $1 billion in revenue. This is a standard earnings release disclosure under Item 2.02, furnished as Exhibit 99.1.

View raw filing on EDGAR →

Madison Square Garden Sports Corp. (MSGS)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

Madison Square Garden Sports Corp. disclosed its financial results for the fourth quarter and full fiscal year ended June 30, 2026 via press release attached as Exhibit 99.1. The disclosure includes consolidated statements of operations, balance sheet data, and detailed revenue and operating income analysis. This is a standard earnings release under Item 2.02, material to investors assessing the company's financial performance and the impact of the Knicks' NBA Championship win on revenues and operating results.

View raw filing on EDGAR →

Ovid Therapeutics Inc. (OVID)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

The filing discloses second quarter 2026 financial results for Ovid Therapeutics, including condensed consolidated statements of operations showing revenue, operating expenses, net loss, and loss per share, along with select balance sheet data as of June 30, 2026. The press release (Exhibit 99.1) explicitly announces "Second Quarter 2026 Financial Results" with detailed financial metrics and comparisons to the prior year period, which is the hallmark of an earnings release under Item 2.02.

View raw filing on EDGAR →

APPLIED MATERIALS INC /DE (AMAT)

8-K Earnings release confidence 99% filed 2026-08-13 Item 2.02

Applied Materials announced third quarter 2026 financial results on August 13, 2026, disclosing record revenue of $9.12 billion (up 25% YoY), GAAP EPS of $3.17 (up 43% YoY), and non-GAAP EPS of $3.50 (up 41% YoY). The press release, attached as Exhibit 99.1, is a standard earnings release with detailed financial results, segment performance, business outlook, and forward-looking guidance. This is a classic Item 2.02 earnings disclosure material to investors assessing the company's financial performance and growth trajectory.

View raw filing on EDGAR →

York Space Systems Inc. (YSS)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

York Space Systems issued a press release on August 13, 2026, announcing financial results for the fiscal quarter ended June 30, 2026, disclosing Q2 2026 revenue of $92.5 million (up 10% YoY), gross profit of $22.2 million, and a net loss of $39.3 million. The filing also includes full-year 2026 revenue guidance of $375–$405 million and discusses backlog, contract wins, and strategic acquisitions. This is a standard quarterly earnings release furnished under Item 2.02.

View raw filing on EDGAR →

Enhanced Group Inc. (APAD)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

Enhanced Group Inc. issued a press release on August 13, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing revenue of $17.7 million, net loss of $61.9 million, and adjusted EBITDA loss of $42.7 million. The press release is furnished as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02, which is material to investors assessing the company's financial performance and operational progress in its first reported public quarter.

View raw filing on EDGAR →

Merlin, Inc. (MRLN)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Merlin, Inc. (the 'Company') issued a press release announcing its financial results for the second quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed financial results including revenue ($2.2M), net loss ($58.4M), and cash position ($183.9M), along with business highlights and forward-looking guidance. This is a material disclosure affecting investor assessment of the registrant's financial performance and operational progress.

View raw filing on EDGAR →

Strive, Inc. (SATA)

8-K Dividend Distribution confidence 95% filed 2026-08-13 Item 8.01

Strive's board declared daily cash dividends of $0.0516 per share of SATA Stock for September 2026 at a 13.00% per annum rate, with a detailed payment schedule. This is a material dividend declaration affecting shareholder returns and capital allocation, disclosed under Item 8.01 (Other Events) as a formal board action with specific payment dates and amounts.

View raw filing on EDGAR →

Nomad Foods Ltd (NOMD)

6-K Earnings release confidence 98% filed 2026-08-13 EX-99.1

This is a press release disclosing Nomad Foods' second quarter and first six months 2026 financial results, including revenue (€724m for Q2, down 3.1%), Adjusted EBITDA (€124m for Q2, down 4.3%), and Adjusted EPS (€0.39 for Q2, down 2.5%). The document includes condensed consolidated interim financial statements, cash flow data, and updated full-year guidance. This is a discrete earnings announcement, not a periodic financial report filing.

View raw filing on EDGAR →

HSBC HOLDINGS PLC (HBCYF)

6-K Debt Issuance confidence 85% filed 2026-08-13

HSBC announced pricing terms for tender offers to repurchase four series of outstanding notes with an aggregate maximum tender amount of $6.75 billion. While technically a repurchase (debt retirement), the filing discloses the creation of a direct financial obligation through the issuance of $6.75 billion in new notes (5.243%, 5.729%, and floating-rate notes due 2032–2037) to finance the tender offers. This is a material debt capital transaction affecting the registrant's financial obligations and capital structure.

View raw filing on EDGAR →

RENTOKIL INITIAL PLC /FI (RKLIF)

6-K Exec appointment confidence 92% filed 2026-08-13

The filing announces three executive appointments: Phill Wood as CEO of the newly formed International Division (effective immediately), Rafael Carrasco as CEO of North America Division (joined 3 August 2026), and Matt Jochim as Group Chief Transformation Officer (effective 7 September 2026). These are material leadership changes affecting the Company's executive structure and strategic execution, particularly the appointment of a new Group Chief Transformation Officer to the Executive Leadership Team reporting directly to the CEO.

View raw filing on EDGAR →

Haleon plc (HLNCF)

6-K Debt Issuance confidence 98% filed 2026-08-13

Haleon announces the launch and pricing of a $2 billion three-tranche fixed-rate USD bond offering ($600M due 2029 at 4.625%, $600M due 2031 at 4.875%, $800M due 2036 at 5.375%), with settlement scheduled for 21 August 2026. The company intends to use proceeds to repurchase outstanding 3.375% Senior Notes due March 2027 and for general corporate purposes. This is a material creation of direct financial obligations under Item 2.03.

View raw filing on EDGAR →

HSBC HOLDINGS PLC (HBCYF)

6-K Debt Issuance confidence 75% filed 2026-08-13

HSBC announced results of tender offers for four series of outstanding notes, accepting approximately $4.9 billion in aggregate consideration for repurchase and retirement of debt. While this is technically a debt retirement/repurchase rather than issuance of new debt, the filing also discloses concurrent pricing of $6.75 billion in new senior unsecured notes (due 2032, 2037, and 2032) on August 5, 2026, which satisfied the "New Issue Condition" for the tender offers. The combined debt management activity—retiring existing notes while issuing new ones—constitutes material debt activity affecting the registrant's capital structure and financial obligations.

View raw filing on EDGAR →

PEDEVCO CORP (PED)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

PEDEVCO issued a press release on August 13, 2026 announcing financial results for Q2 2026 and the first half of 2026, disclosing revenue of $46.1 million (up 561% YoY), net income of $17.5 million (vs. a loss in Q2 2025), and Adjusted EBITDA of $18.7 million. The filing explicitly states the press release is furnished as Exhibit 99.1 and is incorporated by reference, which is the standard format for earnings releases under Item 2.02. The results show material improvements in production, profitability, and balance sheet metrics following the October 2025 Juniper Merger.

View raw filing on EDGAR →

TSS, Inc. (TSSI)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

TSS, Inc. issued a press release on August 13, 2026, reporting financial results for the three and six months ended June 30, 2026. The Item 2.02 disclosure explicitly states the company "issued a press release reporting certain financial results" and furnishes the press release as Exhibit 99.1. The exhibit contains detailed quarterly and year-to-date financial statements, revenue breakdowns by segment, gross profit, net income, diluted EPS, and Adjusted EBITDA metrics—all hallmarks of an earnings release. The company also announced a conference call to discuss results, further confirming this is a standard quarterly earnings disclosure.

View raw filing on EDGAR →

Idaho Strategic Resources, Inc. (IDR)

8-K Earnings release confidence 95% filed 2026-08-13 Item 7.01

The filing discloses consolidated operating and financial results for Q2 2026 ending June 30, 2026, presented in a press release format with detailed financial statements (income statement and balance sheet). The disclosure includes revenue of $10,732,335 (up 13.25% YoY), net income of $3,651,596 (up 31.95% YoY), and EPS of $0.23 (up 15% YoY), along with operational metrics. This is a standard quarterly earnings release furnished under Item 7.01 (Regulation FD Disclosure).

View raw filing on EDGAR →

YETI Holdings, Inc. (YETI)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

YETI issued a press release on August 13, 2026 announcing its second quarter 2026 financial results, including net sales of $483.9 million (up 9%), net income per diluted share of $0.94 (up 54%), and an updated full-year 2026 EPS outlook raised to $2.94–$3.00. This is a standard quarterly earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and trajectory.

View raw filing on EDGAR →

VALVOLINE INC (VVV)

8-K Debt Issuance confidence 95% filed 2026-08-13 Item 8.01

Valvoline announced the pricing and commencement of a $600 million offering of 6.125% senior notes due 2034, upsized from the initially announced $500 million. This is a material creation of a direct financial obligation. The filing also discloses concurrent amendment to the revolving credit facility to increase availability from $475 million to $600 million, reduce pricing, and extend maturity. The proceeds will be used to repay existing term loan facilities and pay fees, representing a refinancing transaction intended to strengthen debt maturity profile and enhance liquidity.

View raw filing on EDGAR →

AETHLON MEDICAL INC (AEMD)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

The filing discloses quarterly financial results for the period ended June 30, 2026, including a press release issued on August 13, 2026 (Exhibit 99.1) that reports Q1 fiscal 2027 results with consolidated balance sheets and statements of operations. The Item 2.02 explicitly incorporates Item 7.01 (Regulation FD Disclosure) which contains the earnings announcement, making this a standard earnings release disclosure with financial statements and operational highlights.

View raw filing on EDGAR →

Serina Therapeutics, Inc. (SER)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

The filing discloses quarterly financial results for Q2 2026 (ended June 30, 2026) via a press release issued on August 13, 2026. The Item 2.02 section explicitly states "the Company issued a press release announcing its financial results for the quarter ended June 30, 2026," and the exhibit includes condensed consolidated balance sheets, statements of operations, and cash flows. This is a standard earnings release disclosure material to investors assessing the registrant's financial condition and operational performance.

View raw filing on EDGAR →

T Stamp Inc (IDAI)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

The filing discloses T Stamp Inc.'s financial results for the six months ended June 30, 2026, including net recognized revenue of $1.66 million (22% increase), operating expenses of $6.32 million, and net loss of $4.93 million. The press release attached as Exhibit 99.1 presents these results alongside operational and strategic updates, which is the standard format for an earnings release under Item 2.02.

View raw filing on EDGAR →

Alithya Group inc (ALYAF)

6-K Earnings release confidence 92% filed 2026-08-13 EX-99.1

This is a press release disclosing Alithya's first quarter fiscal 2027 financial results (ended June 30, 2026), including revenues of $105.1 million (down 15.4%), net loss of $2.4 million, and adjusted EBITDA of $5.4 million (down 53.4%). The document explicitly states "Alithya reports first quarter Fiscal 2027 results" and provides comprehensive quarterly financial highlights and analysis. While the release also mentions a strategic review process, the primary disclosure is the quarterly earnings announcement, which is material to investors assessing the company's financial performance and trajectory.

View raw filing on EDGAR →

Charlotte's Web Holdings, Inc. (CWBHF)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

Charlotte's Web issued an earnings release on August 13, 2026, announcing financial results for the three and six months ended June 30, 2026. The disclosure includes detailed quarterly revenue ($10.9M vs. $12.8M YoY), gross profit, operating loss, net loss, and balance sheet metrics. This is a standard earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1, which is the typical format for quarterly financial results disclosure.

View raw filing on EDGAR →

HawkEye 360, Inc. (HAWK)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

HawkEye 360 issued a press release on August 13, 2026, announcing Q2 2026 financial results with revenue of $49.8 million (up 87% YoY), net loss of $15.3 million, backlog of $292.2 million, and full-year 2026 guidance of $215–$220 million.

View raw filing on EDGAR →

HawkEye 360, Inc. (HAWK)

8-K Governance Other confidence 45% filed 2026-08-13 Item 8.01

The company announced early termination of the 180-day lock-up period from its May 2026 IPO, with restricted shares becoming eligible for sale on September 2, 2026, triggered by the company's quarterly blackout period.

View raw filing on EDGAR →

Rocket Lab Corp (RKLB)

8-K M&A activity confidence 95% filed 2026-08-13

This 8-K discloses a pending merger between Rocket Lab Corporation and Iridium Communications Inc., with Rocket Lab as the acquirer. The filing includes the Merger Agreement dated June 28, 2026, merger consideration details ($27.00 cash plus stock consideration with a variable exchange ratio), pro forma financial statements, and auditor consent. The transaction is material and clearly falls under M&A activity (Items 1.01/2.01 equivalent disclosure under Item 8.01 and Item 9.01).

View raw filing on EDGAR →

Rocket Lab Corp (RKLB)

8-K Dilutive issuance confidence 75% filed 2026-08-13 Item 7.01

The filing discloses Rocket Lab's entry into an equity distribution agreement (ATM program) with an aggregate offering price of $1,944,369,826 in common stock. While the company intends to use proceeds to fund the Iridium acquisition and reduce debt, the core disclosure is the establishment of a new equity issuance facility that permits substantial dilution to existing shareholders. The press release explicitly states this is a "replacement" ATM program carrying forward unsold amounts, and the company "may offer and sell" shares at market prices, making this a dilutive equity issuance material to investors assessing capital structure and ownership dilution.

View raw filing on EDGAR →

Sensus Healthcare, Inc. (SRTS)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

This is a clear earnings release for Q2 2026 filed under Item 2.02. The press release discloses quarterly financial results including revenues of $2.3 million (down 68.5% YoY), net loss of $8.7 million per share, and adjusted EBITDA of negative $3 million. The filing includes consolidated statements of operations and balance sheet data, making this a standard quarterly earnings announcement material to investors assessing the company's financial performance.

View raw filing on EDGAR →

Cabaletta Bio, Inc. (CABA)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

Cabaletta Bio announced its financial results for the second quarter ended June 30, 2026, via press release furnished as Exhibit 99.1. The disclosure includes quarterly R&D expenses ($44.4M vs. $37.6M YoY), G&A expenses ($7.6M vs. $8.3M YoY), and cash position ($225.1M as of June 30, 2026), along with operational highlights and clinical milestones. This is a standard quarterly earnings release disclosing results of operations and financial condition under Item 2.02.

View raw filing on EDGAR →

Pharming Group N.V. (PHAR)

6-K Operational Other confidence 85% filed 2026-08-13

The disclosure announces the commercial launch of Joenja (leniolisib) in Japan for APDS patients aged 4 and older, following inclusion on the Japan National Health Insurance drug price list. This represents a material operational and commercial milestone—the first market where Joenja is available for children aged 4–11—that would affect a reasonable investor's assessment of Pharming's commercial progress and market expansion. While not a discrete M&A, financing, or governance event, it is a significant product commercialization milestone in a rare-disease therapeutic area.

View raw filing on EDGAR →

Southland Holdings, Inc. (SLND-WT)

8-K M&A activity confidence 75% filed 2026-08-13 Item 1.01

Southland entered into two material definitive agreements on August 13, 2026: a Financial Assistance Agreement with sureties and a Second Amendment to its Credit Agreement. The Financial Assistance Agreement documents a substantial restructuring of the company's financing, including conversion of $150.86 million in Non-Bonding Financing into senior preferred shares and modification of repayment terms, while the Second Amendment reduces the interest rate from 7.25% + SOFR to 4.00% (capitalized), suspends amortization and financial covenants, and provides material relief during a "Relief Period."

View raw filing on EDGAR →

Solo Brands, Inc. (SBDS)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

Solo Brands issued a press release on August 13, 2026, disclosing financial results for the quarterly period ended June 30, 2026 (Q2 2026). The disclosure includes consolidated and segment-level results with net sales of $88.5 million, net loss of $4.4 million, adjusted EBITDA of $13.5 million, and reaffirmed full-year 2026 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the registrant's financial performance and operational trends.

View raw filing on EDGAR →

T. Rowe Price OHA Select Private Credit Fund

8-K Earnings release confidence 95% filed 2026-08-13 Item 8.01

The filing discloses quarterly financial results for the period ended June 30, 2026, including net investment income per share of $0.61, earnings per share of $0.41, net asset value per share of $25.96, and distributions declared of $0.60 per share. The press release attached as Exhibit 99.1 is a standard earnings announcement for a BDC reporting its quarterly financial performance and investment activity, which is material to investors assessing the fund's performance and distribution capacity.

View raw filing on EDGAR →

Pelthos Therapeutics Inc. (PTHS)

8-K Restatement confidence 98% filed 2026-08-13 Item 4.02

The Audit Committee concluded on August 12, 2026 that the Company's previously issued condensed consolidated financial statements for Q1 2026 should no longer be relied upon due to a misapplication of ASC 820 (Fair Value Measurements) in valuing convertible debt. The restatement involves material adjustments: a $15.8 million increase in convertible debt liabilities, a $14.8 million increase in non-cash fair value expense, and a $14.8 million increase in accumulated deficit. The filing explicitly states "the Company will restate the condensed consolidated financial statements for the Affected Period" and discloses a material weakness in internal controls over fair value measurement of Level 3 convertible debt instruments.

View raw filing on EDGAR →

Pelthos Therapeutics Inc. (PTHS)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

Pelthos Therapeutics disclosed second quarter 2026 financial results via press release, reporting net product revenue of $15.4 million (45% QoQ growth) and a net loss of $(23.4) million, along with operational highlights including Zelsuvmi unit dispensing growth.

View raw filing on EDGAR →

McGraw Hill, Inc. (MH)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

McGraw Hill issued a press release on August 13, 2026, announcing financial results for the fiscal first quarter ended June 30, 2026, including total revenue of $549.9 million, net income of $57.9 million, Adjusted EBITDA of $207.0 million, segment performance, and fiscal year 2027 guidance.

View raw filing on EDGAR →

McGraw Hill, Inc. (MH)

8-K Shareholder vote confidence 95% filed 2026-08-13 Item 5.07

McGraw Hill disclosed the results of its August 11, 2026 annual stockholder meeting, including election of four directors (Simon Allen, Mary Ann Sigler, Guhan Subramanian, Eric Worley), advisory approval of executive compensation, determination of annual frequency for future advisory compensation votes, and ratification of Ernst & Young LLP as independent auditor.

View raw filing on EDGAR →

Bending Spoons S.p.A.

6-K Earnings release confidence 95% filed 2026-08-13

The 6-K body explicitly states that on August 13, 2026, Bending Spoons issued a press release announcing its results for Q2 2026, with the press release furnished as Exhibit 99.1 and quarterly unaudited financial statements as Exhibit 99.2. This is a discrete earnings announcement event, not a periodic financial report filing itself. Quarterly earnings releases are material to investors and constitute a standard earnings_release classification.

View raw filing on EDGAR →

Inhibrx Biosciences, Inc. (INBX)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

Inhibrx issued a press release on August 13, 2026 announcing financial results for the three and six months ended June 30, 2026, including revenue, operating expenses, net loss, cash position, and balance sheet data. This is a standard quarterly earnings disclosure furnished under Item 2.02, with the press release attached as Exhibit 99.1. The disclosure is material as it reports significant financial metrics including a net loss of $36.7 million for Q2 2026 and changes in the company's cash and debt position.

View raw filing on EDGAR →

Newsmax Inc. (NMAX)

8-K Earnings release confidence 97% filed 2026-08-13 Item 2.02

Newsmax Inc. issued a press release announcing Q2 2026 financial results, reporting record quarterly revenues of $54.1 million (16.5% year-over-year growth), net income of $2.9 million (the company's first profitable quarter as a public company), and adjusted EBITDA of $5.7 million, along with detailed segment breakdowns and forward guidance.

View raw filing on EDGAR →

Figure Technology Solutions, Inc. (FGRS)

8-K Earnings release confidence 98% filed 2026-08-13 Item 2.02

Figure Technology Solutions issued a press release on August 13, 2026 announcing financial results for the three and six months ended June 30, 2026, disclosing strong quarterly performance including 132% year-over-year volume growth, net revenue of $226 million (113% YoY increase), and net income of $87 million (192% YoY increase). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial performance and operational trajectory.

View raw filing on EDGAR →

Fermi Inc. (FRMI)

8-K Earnings release confidence 95% filed 2026-08-13 Item 2.02

Fermi Inc. issued its earnings release on August 13, 2026, announcing financial results for the second quarter ended June 30, 2026. The disclosure includes condensed consolidated balance sheets and statements of operations, along with detailed operational and financial highlights. This is a standard quarterly earnings release filed under Item 2.02 (Results of Operations and Financial Condition), furnished as Exhibit 99.1, and is material to investors assessing the company's financial condition and operational progress.

View raw filing on EDGAR →

AMERICAN EXPRESS CO (AXP)

8-K Dividend Distribution confidence 72% filed 2026-08-12 Item 3.03

American Express issued 1,600 shares of 6.450% Fixed Rate Reset Noncumulative Preferred Shares, Series E, establishing new dividend rights and creating restrictions on common and parity preferred dividends if Series E dividends are not paid.

View raw filing on EDGAR →

AMERICAN EXPRESS CO (AXP)

8-K Dilutive issuance confidence 75% filed 2026-08-12 Item 8.01

American Express closed the sale of 1,600 Depositary Shares representing Series E Preferred Shares on August 12, 2026, pursuant to an underwriting agreement, creating a new preferred equity security with fixed-rate dividend obligations.

View raw filing on EDGAR →

CARPENTER TECHNOLOGY CORP (CRS)

8-K Exec appointment confidence 92% filed 2026-08-12 Item 5.02

Kenneth J. Giacobbe was appointed to Carpenter Technology's Board of Directors as a Class III director, effective August 11, 2026. The appointment was accompanied by the concurrent departures of Howard Yu (resignation effective October 6, 2026) and Colleen Pritchett (not seeking re-election), with Giacobbe's extensive CFO experience at Howmet Aerospace making the board composition change material to investors.

View raw filing on EDGAR →

SOUTHWEST AIRLINES CO (LUV)

8-K Debt Issuance confidence 92% filed 2026-08-12 Item 2.03

Southwest Airlines entered into a new $2 billion five-year revolving credit facility agreement on August 10, 2026, with JPMorgan Chase and Citibank as co-administrative agents, replacing an expiring 2016 credit facility. The new facility includes an accordion feature allowing expansion to $3 billion and contains standard covenants including a Collateral Coverage Test and Coverage Ratio requirement.

View raw filing on EDGAR →

VISHAY INTERTECHNOLOGY INC (VSH)

8-K Dividend Distribution confidence 98% filed 2026-08-12 Item 8.1

The filing discloses a quarterly cash dividend declaration of $0.10 per share on common and Class B common stock, payable September 24, 2026 to stockholders of record as of September 10, 2026. This is a routine but material dividend distribution that affects shareholder returns and is disclosed via press release attached as Exhibit 99.1.

View raw filing on EDGAR →

HOME DEPOT, INC. (HD)

8-K Exec departure confidence 75% filed 2026-08-12 Item 5.02

Edward P. Decker, Chair, President and CEO, is taking a temporary medical leave from his executive duties, with interim successors designated to oversee operations during his absence. While characterized as temporary with an expected return within months, the immediate removal of the CEO from active duty is a material event affecting the registrant's leadership structure.

View raw filing on EDGAR →

BRINKER INTERNATIONAL, INC (EAT)

8-K Earnings release confidence 95% filed 2026-08-12 Item 2.02

Brinker International issued a press release on August 12, 2026 announcing fourth quarter and full year fiscal 2026 financial results, including company sales of $1,521.2 million (Q4) and $5,750.9 million (FY), net income per diluted share of $2.99 (Q4) and $10.87 (FY), comparable restaurant sales growth of 8.1% for the year, and provided fiscal 2027 guidance with estimated total revenues of $6.15–$6.27 billion.

View raw filing on EDGAR →